Mara Rosenberg
Overview
Explore the profile of Mara Rosenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
9188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosenberg M, Eckstrom E
Aging Ment Health
. 2023 Feb;
27(10):2011-2018.
PMID: 36762673
Objectives: The aim of this cross-sectional, descriptive study was to characterize the impact of modifiable activities on older adult mental health during the COVID-19 pandemic and to understand the interaction...
2.
Stover E, Oh C, Keskula P, Choudhury A, Tseng Y, Adalsteinsson V, et al.
Prostate
. 2022 Jan;
82(5):584-597.
PMID: 35084050
Background: Primary and metastatic prostate cancers have low mutation rates and recurrent alterations in a small set of genes, enabling targeted sequencing of prostate cancer-associated genes as an efficient approach...
3.
Whalley J, Buchhalter I, Rheinbay E, Raine K, Stobbe M, Kleinheinz K, et al.
Nat Commun
. 2020 Oct;
11(1):5040.
PMID: 33028839
Bringing together cancer genomes from different projects increases power and allows the investigation of pan-cancer, molecular mechanisms. However, working with whole genomes sequenced over several years in different sequencing centres...
4.
Amin-Mansour A, George S, Sioletic S, Carter S, Rosenberg M, Taylor-Weiner A, et al.
Clin Cancer Res
. 2019 Jun;
25(16):5135-5142.
PMID: 31164371
Purpose: Leiomyosarcoma and liposarcoma are common subtypes of soft tissue sarcoma (STS). Patients with metastatic leiomyosarcoma or dedifferentiated liposarcoma (DDLPS) typically have worse outcomes compared with localized leiomyosarcoma or well-differentiated...
5.
Dunlap J, Leonard J, Rosenberg M, Cook R, Press R, Fan G, et al.
Am J Hematol
. 2019 May;
94(8):913-920.
PMID: 31145495
Acute myeloid leukemia (AML) is a genetically heterogeneous disease with a clinical course predicted by recurrent cytogenetic abnormalities and/or gene mutations. The NPM1 insertion mutations define the largest distinct genetic...
6.
Nechiporuk T, Kurtz S, Nikolova O, Liu T, Jones C, DAlessandro A, et al.
Cancer Discov
. 2019 May;
9(7):910-925.
PMID: 31048320
To study mechanisms underlying resistance to the BCL2 inhibitor venetoclax in acute myeloid leukemia (AML), we used a genome-wide CRISPR/Cas9 screen to identify gene knockouts resulting in drug resistance. We...
7.
Edwards 5th D, Watanabe-Smith K, Rofelty A, Damnernsawad A, Laderas T, Lamble A, et al.
Blood
. 2018 Nov;
133(6):588-599.
PMID: 30425048
To identify new therapeutic targets in acute myeloid leukemia (AML), we performed small-molecule and small-interfering RNA (siRNA) screens of primary AML patient samples. In 23% of samples, we found sensitivity...
8.
Chapuy B, Stewart C, Dunford A, Kim J, Kamburov A, Redd R, et al.
Nat Med
. 2018 Jun;
24(8):1290-1291.
PMID: 29955182
In the version of this article originally published, an asterisk was omitted from Fig. 1a. The asterisk has been added to the figure. Additionally, a "NOTCH2" label was erroneously included...
9.
Chapuy B, Stewart C, Dunford A, Kim J, Kamburov A, Redd R, et al.
Nat Med
. 2018 Jun;
24(8):1292.
PMID: 29955181
In the version of this article originally published, some text above the "Tri-nucleotide sequence motifs" label in Fig. 2a appeared incorrectly. The text was garbled and should have appeared as...
10.
Taylor-Weiner A, Stewart C, Giordano T, Miller M, Rosenberg M, Macbeth A, et al.
Nat Methods
. 2018 Jun;
15(7):531-534.
PMID: 29941871
Comparison of sequencing data from a tumor sample with data from a matched germline control is a key step for accurate detection of somatic mutations. Detection sensitivity for somatic variants...